| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8542386 | Journal of Pharmacy Research | 2013 | 5 Pages | 
Abstract
												Efavirenz significantly alters the pharmacokinetics of amodiaquine, exposure to amodiaquine is increased leading to toxic effect, and reduction in the antimalarial activity since amodiaquine is a prodrug that relies on its active metabolite against malaria parasites.
											Related Topics
												
													Health Sciences
													Pharmacology, Toxicology and Pharmaceutical Science
													Pharmacology, Toxicology and Pharmaceutics (General)
												
											Authors
												Julius O. Soyinka, Cyprian O. Onyeji, Thomas I. Nathaniel, Olugbenga O. Odunfa, Benjamin U. Ebeshi, 
											